Use of a needle-free injector in the treatment of palmar-plantar hyperhidrosis with botulinum A toxin; Pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20190211003

Enrollment

Registered

2019-02-11

Start date

2019-02-14

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild and severe palmar&#45

Interventions

deliver botulinum toxin A using a needle&#45

free injector Dermojet,deliver botulinum toxin A using a needle&#45

free injector Innojector

Experimental Device,Experimental Device

Dermojet,Innojector

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18-60 years palmar and plantar hyperhidrosis

Exclusion criteria

Exclusion criteria: currently receive other treatments eg. topical/oral treatments, iontophoresis history of botulinum toxin injection on the palm and sole pregnant patients or lactating infection or wound at the palm and sole history of skin diseases or conditions that might interfere with the treatment outcome history of allergic to botulinum toxin type A and its component eg. albumin currently on immunosuppressive drugs history of skin cancer

Design outcomes

Primary

Measure	Time frame
sweat reduction 6months minor iodine starch test	—

Secondary

Measure	Time frame
sweat reduction and quality of life 6 month hyperhidrosis severity score, hyperhidrosis quality of life	—

Countries

Thailand

Contacts

Public ContactMarisa Pongprutthipan

Division of dermatology, Department of medicine, Faculty of Medicine, Chulalongkorn University

dr_marisa@yahoo.com085-3620400

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Use of a needle&#45;free injector in the treatment of palmar&#45;plantar hyperhidrosis with botulinum A toxin; Pilot study